It is a chemicals and materials private limited company based in Phase-1, Hyderabad, Telangana, India, established in 2019.
2019 | Phase-1, Hyderabad, Telangana, India | ActiveSpanus Pharmaceuticals Private Limited, a active private limited company, was established on 25 January 2019 in Phase-1, Hyderabad, Telangana, India. Engaging in organic chemicals & compounds within the chemicals and materials sector, it holds CIN: U24239TG2019PTC130023. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 6 professional, Its leadership includes Udaya Kiran Perla (Managing Director), Sri Chandana Modukuri (Director), Rama Subrahmanyam Sana (Director). Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at Flat No. 201, 2Nd Floor, Plot No. 239 Sri Rama Nilayam, Kamalapuri Colony,, Phase-1, Hyderabad, Telangana, 500073.
U24239TG2019PTC130023
130023
25 January 2019
₹1.00 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Spanus Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Udaya Kiran Perla | Managing Director | 25 Jan 2019 | Current |
| Sri Chandana Modukuri | Director | 25 Jan 2019 | Current |
| Rama Subrahmanyam Sana | Director | 25 Jan 2019 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Spanus Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 19.44% decrease. The company also saw a substantial improvement in profitability, with a 38.08% increase in profit. The company's net worth observed a substantial decline by a decrease of 64.22%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Spanus Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Spanus Pharmaceuticals has a workforce of 6 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Spanus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spanus Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Spanus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.
Progress on Spanus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad. was documented.
The activity Udaya Kiran Perla was appointed as a Managing Director was appointed as a Managing Director on 25 Jan 2019 & has been associated with this company since 6 years 10 months . was completed.
Progress on Sri Chandana Modukuri was appointed as a Director was appointed as a Director on 25 Jan 2019 & has been associated with this company since 6 years 10 months . was documented.
Rama Subrahmanyam Sana was appointed as a Director was appointed as a Director on 25 Jan 2019 & has been associated with this company since 6 years 10 months . was recorded as a recent event.
Progress on Spanus Pharmaceuticals Private Limited was registered on 25 Jan 2019 with Roc Hyderabad & aged 6 years 10 months as per MCA records. was documented.
The CIN of Spanus Pharmaceuticals Private Limited is U24239TG2019PTC130023.
Spanus Pharmaceuticals Private Limited is headquartered at Flat No. 201, 2Nd Floor, Plot No. 239 Sri Rama Nilayam, Kamalapuri Colony,, Phase-1, Hyderabad, Telangana, 500073.
Spanus Pharmaceuticals Private Limited was incorporated on 25 January 2019.
The current directors of Spanus Pharmaceuticals Private Limited are
The primary industry of Spanus Pharmaceuticals Private Limited is Chemicals And Materials.
Spanus Pharmaceuticals Private Limited is unlisted.
The authorized capital of Spanus Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Spanus Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX